The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Survey of unlicensed and off label drug use in paediatric wards in European countries
Open accessAbstract
Abstract Objective: To determine the extent of use of unlicensed and off label drugs in children in hospital in five European countries. Design: Prospective study of drugs administered to children in general paediatric medical wards over four weeks. Setting: Children9s wards in five hospitals (one each in the United Kingdom, Sweden, Germany, Italy, and the Netherlands). Subjects: Children aged 4 days to 16 years admitted to general paediatric medical wards. Main outcome measure: Proportion of drugs that were used in an unlicensed or off label manner. Results: 2262 drug prescriptions were administered to 624 children in the five hospitals. Almost half of all drug prescriptions (1036; 46%) were either unlicensed or off label. Of these 1036, 872 were off label and 164 were unlicensed. Over half of the patients (421; 67%) received an unlicensed or off label drug prescription. Conclusions: Use of off label or unlicensed drugs to treat children is widespread. This problem is likely to affect children throughout Europe and requires European action. Key messages Many drugs are not tested in children, which means that they are not specifically licensed for use in children Licensed drugs are often prescribed outside the terms of the product license (off label) in relation to age, indication, dose of frequency, route of administration, or formulation Over two thirds (67%) of 624 children admitted to wards in five European hospitals received drugs prescribed in an unlicensed or off label manner 39% of the 2262 drug prescriptions given to children were off label The problem of off label and unlicensed drug prescribing in children is a European problem that requires European action
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study
Turner, S., Nunn, A., Fielding, K., & Choonara, I. (1999) · Acta Paediatrica · doi:10.1080/08035259950168469 · Cited by 411
Unlicensed and off label drug use in paediatric wards: prospective study
Turner, S., Longworth, A., Nunn, A. J., & Choonara, I. (1998) · BMJ · doi:10.1136/bmj.316.7128.343 · Cited by 317
Unlicensed and off label drug use in neonates
Conroy, S., McIntyre, J., & Choonara, I. (1999) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.80.2.f142 · Cited by 286
Self-citationUse of "off-label" and unlicensed drugs in paediatric intensive care unit
Turner, S. C. M., Gill, A. M., Nunn, T., Hewitt, B., & Choonara, I. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91182-4 · Cited by 129
Impicciatore, P., & Choonara, I. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00981.x · Cited by 75
Choonara, I., & DUNNE, J. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.78.5.402 · Cited by 26
Cited by
Antithrombotic Therapy in Neonates and Children
Monagle, P., Chan, A. K. C., Goldenberg, N. A., Ichord, R. N., Journeycake, J. M., Nowak-Göttl, U., & Vesely, S. K. (2012) · Chest · doi:10.1378/chest.11-2308 · Cited by 1,491
Antithrombotic Therapy in Neonates and Children
Monagle, P., Chalmers, E., Chan, A., deVeber, G., Kirkham, F., Massicotte, P., & Michelson, A. D. (2008) · Chest · doi:10.1378/chest.08-0762 · Cited by 676
Johnson, T. N., Rostami-Hodjegan, A., & Tucker, G. T. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645090-00005 · Cited by 530
Impicciatore, P., Choonara, I., Clarkson, A., Provasi, D., Pandolfini, C., & Bonati, M. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01407.x · Cited by 513
Joseph, P. D., Craig, J. C., & Caldwell, P. H. Y. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12305 · Cited by 393
Metadata
- Authors
- Conroy, S.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2000-01-08
- Volume
- 320
- Issue
- 7227
- Pages
- 79-82
- ISSN
- 0959-8138 (ISSN-L)
- OpenAlex
- W2155916653
- Cited by
- 735
- References
- 6
- FWCI
- 34.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.